GeminIQ Website Logo

Viewing KRMD free

Subscribe for full history, 90+ metrics, screener, watchlist...

KORU Medical Systems, Inc.

KRMD

Subscribe to unlock 17+ years of data

Financial Statements

Values in Millions ($)
2026-06-30
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Financial statements beyond 3 years are for subscribers only.

Unlock 17+ years of income statements, balance sheets, and cash flow statements

Start 7-day free trial
Subscriber-only column
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value
89988910910111111
Accounts Receivable Net Current
-66556656444
Inventory Net
544443343335
Other Receivables
10000000-001
Prepaid Expense Current
111101110111
Assets Current
202120191819191919192022
Property Plant And Equipment Net
444445454444
Finite Lived Intangible Assets Net
211111111111
Operating Lease Right Of Use Asset
333333333344
Deferred Income Tax Assets Net
-----------5
Other Assets Noncurrent
000000000000
Assets
282928272627272727282835
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current
332212222211
Accrued Liabilities Current
355544432121
Notes Payable Current
---0-000-000
Other Liabilities Current
000000000011
Employee Related Liabilities Current
101011110100
Finance Lease Liability Current
-00000000000
Operating Lease Liability Current
000000000000
Liabilities Current
798868765544
Finance Lease Liability Noncurrent
-00000000000
Operating Lease Liability Noncurrent
333333333333
Liabilities
1012111191110109888
Stockholders Equity
Common Stock Value
100000000000
Additional Paid In Capital Common Stock
575552515150504948484747
Treasury Stock Value
-6-6-4-4-4-4-4-4-4-4-4-4
Retained Earnings Accumulated Deficit
-33-33-32-32-31-31-29-28-26-25-23-16
Stockholders Equity
181717161716171819192027
Liabilities And Stockholders Equity
282928272627272727282835
Allowance For Doubtful Accounts Receivable Current
---00--00000
Finite Lived Intangible Assets Accumulated Amortiz…
11110-000000
Deferred Rent Receivables Net Noncurrent
--------766-
Common Stock Par Or Stated Value Per Share
0.010.010.010.010.010.010.010.010.010.010.010.01
Common Stock Shares Authorized
757575757575757575757575
Common Stock Shares Issued
505050505050494949494949
Shares Outstanding
464646464646464646464646
Treasury Stock Common Shares
-----------3
Treasury Stock Preferred Shares
44333333333-

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Custom Table

0/5
Search a metric to start building a table

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Interactive Financial Visualizations

0/1
Search a metric to start building a visual

Subscribe to unlock 17+ years of data

Earnings Market Reaction

Fiscal Year
Q1 1 Month
Q1 2 Month
Q1 3 Month
Q2 1 Month
Q2 2 Month
Q2 3 Month
Q3 1 Month
Q3 2 Month
Q3 3 Month
Q4 1 Month
Q4 2 Month
Q4 3 Month
20261.25%11.22%-4.49%---------
2025-0.74%33.46%27.21%29.45%21.47%30.06%47.35%48.41%42.59%0.23%-5.57%-5.80%
2024-2.22%17.78%12.00%18.31%30.05%18.78%18.75%21.88%37.19%-30.49%-13.11%-17.68%
2023---10.55%13.92%-2.53%4.57%12.10%-3.65%17.45%9.43%0.47%

Earnings Market Reaction data beyond 3 years is for subscribers only.

Unlock the full earnings market reaction history

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics
2026-06-30
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Metric history beyond 3 years is for subscribers only.

Unlock 17+ years of history across 90+ calculated metrics

Start 7-day free trial
Subscriber-only column
Liquidity Ratios
Current Ratio
2.72
2.33
2.44
2.48
2.91
2.44
2.66
2.99
3.77
4.01
4.55
5.14
Quick Ratio
2.00
1.70
1.88
1.78
2.17
1.92
2.16
2.22
3.17
3.19
3.49
3.70
Working Capital
12.33M
11.74M
11.79M
11.59M
11.53M
11.20M
11.93M
12.60M
14.23M
14.63M
15.80M
17.46M
Leverage & Debt
Debt to Equity
0.55
0.69
0.65
0.65
0.54
0.67
0.62
0.54
0.46
0.44
0.40
0.29
Interest Coverage TTM
-5.86
-8.61
-10.13
-7.19
-8.13
-11.07
-14.50
-62.43
-
-
-
-
Debt Ratio
0.35
0.41
0.40
0.39
0.35
0.40
0.38
0.35
0.31
0.30
0.28
0.22
Efficiency & Turnover
Asset Turnover TTM
1.69
1.55
1.48
1.43
1.40
1.28
1.21
1.02
0.97
0.89
0.81
0.74
Days Sales Outstanding TTM
-
50.34
52.94
49.40
53.37
53.80
52.97
52.57
56.18
53.26
48.66
58.05
Receivables Turnover TTM
-
7.25
6.89
7.39
6.84
6.78
6.89
6.94
6.50
6.85
7.50
6.29
Per Share Metrics
Diluted EPS TTM
-0.04
-0.05
-0.06
-0.08
-0.10
-0.12
-0.13
-0.26
-0.26
-0.29
-0.30
-0.18
Free Cash Flow Per Share TTM
0.01
-0.01
-0.03
-0.01
-0.06
-0.04
-0.04
-0.04
-0.02
-0.03
-0.12
-0.12
Dividend Per Share TTM
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Margin Metrics
Gross Profit Margin TTM
62.43%
61.93%
62.26%
62.32%
63.15%
63.49%
63.40%
62.82%
62.49%
60.24%
58.59%
57.38%
Operating Profit Margin TTM
-3.66%
-5.99%
-7.23%
-10.28%
-13.16%
-16.33%
-19.16%
-22.05%
-23.18%
-31.29%
-36.01%
-36.91%
Net Profit Margin TTM
-4.03%
-5.27%
-6.41%
-9.50%
-12.25%
-15.10%
-18.03%
-37.42%
-38.16%
-45.24%
-48.18%
-28.78%
Growth Metrics
Net Revenue Growth (1Y)
22.41%
23.30%
22.23%
22.12%
19.57%
19.65%
17.98%
11.57%
4.70%
0.96%
2.23%
6.04%
Net Income Growth (1Y)
-59.70%
-56.98%
-56.52%
-68.99%
-61.60%
-60.07%
-55.85%
45.08%
45.01%
55.44%
58.65%
6.44%
EPS Growth (1Y)
-59.61%
-57.33%
-56.88%
-71.40%
-61.92%
-60.31%
-56.04%
44.41%
44.36%
54.68%
56.57%
5.03%
Valuation Metrics
P/E TTM
-106.38
-87.90
-101.73
-51.29
-36.63
-22.05
-29.07
-10.46
-10.32
-8.13
-8.15
-14.93
P/B TTM
10.72
11.84
15.74
11.56
10.01
7.15
10.49
7.06
6.49
5.64
5.50
4.49
P/S TTM
4.29
4.63
6.52
4.87
4.49
3.33
5.24
3.91
3.94
3.68
3.93
4.30
Market Cap
193.55M
200.30M
268.35M
190.40M
165.37M
116.79M
176.34M
125.17M
121.40M
107.88M
111.95M
123.23M
Enterprise Value
185.26M
191.70M
259.68M
182.51M
157.58M
108.49M
167.35M
117.11M
111.31M
97.62M
101.21M
113.34M
Calculated Values
Free Cash Flow TTM
379.38K
-649.96K
-1.30M
-646.85K
-2.67M
-1.91M
-1.70M
-1.70M
-1.08M
-1.22M
-5.68M
-5.46M
Net Debt
-8.29M
-8.59M
-8.67M
-7.89M
-7.79M
-8.31M
-8.99M
-8.06M
-10.09M
-10.26M
-10.74M
-9.89M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of data

Insider Transactions

2026-06-11Purchase
Owner: Kalbermatten, Adam R
Title: President-Chief Commercial Off
Shares: 12,500
Price/Share: $3.94
Value: $49,250.00
Shares Owned: 312,500
Relationship: Officer
Ownership: Direct
2026-05-18Purchase
Owner: Schiller, Eric
Title: Chief Technology Officer
Shares: 5,000
Price/Share: $3.91
Value: $19,550.00
Shares Owned: 5,000
Relationship: Officer
Ownership: Direct
2026-05-15Purchase
Owner: Tharby, Linda M
Title: Chief Executive Officer
Shares: 1,191
Price/Share: $3.92
Value: $4,668.72
Shares Owned: 620,622
Relationship: Director,Officer
Ownership: Direct
2026-05-14Purchase
Owner: Adams, Thomas Edward
Title: Chief Financial Officer
Shares: 5,500
Price/Share: $3.88
Value: $21,340.00
Shares Owned: 308,147
Relationship: Officer
Ownership: Direct
2026-05-14Purchase
Owner: Pazdan, Christopher
Title: Chief Operating Officer
Shares: 5,000
Price/Share: $3.88
Value: $19,400.00
Shares Owned: 305,131
Relationship: Officer
Ownership: Direct

Subscribe to unlock 17+ years of data

Institutional Ownership

No data available for chart
2026-03-31
44.70%
Inst. Shares: 20,727,155
Shares Outstanding: 46,364,905
2025-12-31
44.98%
Inst. Shares: 20,776,019
Shares Outstanding: 46,187,077
2025-09-30
42.10%
Inst. Shares: 19,443,101
Shares Outstanding: 46,187,077
2025-06-30
41.66%
Inst. Shares: 19,154,026
Shares Outstanding: 45,981,826
2025-03-31
37.63%
Inst. Shares: 17,302,546
Shares Outstanding: 45,981,826

KORU Medical Systems, Inc. (KRMD) — SEC Financial Statements & Analysis

KORU Medical Systems, Inc. (KRMD) is a surgical & medical instruments & apparatus company, incorporated in DE. KORU Medical Systems, Inc. trades on Nasdaq as: KRMD. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), KORU Medical Systems, Inc. reported a 22.41% year-over-year revenue growth, a Gross Profit Margin of 62.43% (TTM), a Debt-to-Equity ratio of 0.55x, a Price-to-Sales (P/S) ratio of 4.29x (TTM), a Price-to-Book (P/B) ratio of 10.72x (TTM), at a market cap of $193.55M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y
22.41%
Gross Profit Margin TTM
62.43%
Debt To Equity
0.55x
P/S TTM
4.29x
P/B TTM
10.72x
Market Cap
$193.55M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is KORU Medical Systems, Inc. in?

KORU Medical Systems, Inc. (KRMD) operates in the Surgical & Medical Instruments & Apparatus industry.

What is KRMD's market cap?

KORU Medical Systems, Inc. (KRMD) has a market capitalization of $193.55M as of 2026-06-30.

What exchange does KRMD trade on?

KORU Medical Systems, Inc. (KRMD) trades on the Nasdaq.

Where is KORU Medical Systems, Inc. incorporated?

KORU Medical Systems, Inc. is incorporated in DE.

Wall Street's data.
Main Street's price.